chr16-3606556-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_032444.4(SLX4):​c.678C>T​(p.His226His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0356 in 1,614,068 control chromosomes in the GnomAD database, including 3,877 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.089 ( 1447 hom., cov: 32)
Exomes 𝑓: 0.030 ( 2430 hom. )

Consequence

SLX4
NM_032444.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.120

Publications

11 publications found
Variant links:
Genes affected
SLX4 (HGNC:23845): (SLX4 structure-specific endonuclease subunit) This gene encodes a protein that functions as an assembly component of multiple structure-specific endonucleases. These endonuclease complexes are required for repair of specific types of DNA lesions and critical for cellular responses to replication fork failure. Mutations in this gene were found in patients with Fanconi anemia. [provided by RefSeq, Sep 2016]
SLX4 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group P
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 16-3606556-G-A is Benign according to our data. Variant chr16-3606556-G-A is described in ClinVar as Benign. ClinVar VariationId is 262057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.12 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.249 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLX4NM_032444.4 linkc.678C>T p.His226His synonymous_variant Exon 3 of 15 ENST00000294008.4 NP_115820.2
SLX4XM_024450471.2 linkc.678C>T p.His226His synonymous_variant Exon 3 of 15 XP_024306239.1
SLX4XM_011522715.4 linkc.678C>T p.His226His synonymous_variant Exon 3 of 15 XP_011521017.1
SLX4XR_007064923.1 linkn.1327C>T non_coding_transcript_exon_variant Exon 3 of 13

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLX4ENST00000294008.4 linkc.678C>T p.His226His synonymous_variant Exon 3 of 15 5 NM_032444.4 ENSP00000294008.3
SLX4ENST00000466154.5 linkn.973C>T non_coding_transcript_exon_variant Exon 2 of 7 1
SLX4ENST00000486524.1 linkn.1306C>T non_coding_transcript_exon_variant Exon 3 of 4 2
SLX4ENST00000697858.1 linkn.19C>T non_coding_transcript_exon_variant Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0889
AC:
13520
AN:
152064
Hom.:
1444
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.253
Gnomad AMI
AF:
0.0209
Gnomad AMR
AF:
0.0525
Gnomad ASJ
AF:
0.0366
Gnomad EAS
AF:
0.0457
Gnomad SAS
AF:
0.126
Gnomad FIN
AF:
0.0134
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0136
Gnomad OTH
AF:
0.0843
GnomAD2 exomes
AF:
0.0492
AC:
12359
AN:
251426
AF XY:
0.0493
show subpopulations
Gnomad AFR exome
AF:
0.260
Gnomad AMR exome
AF:
0.0270
Gnomad ASJ exome
AF:
0.0314
Gnomad EAS exome
AF:
0.0512
Gnomad FIN exome
AF:
0.0144
Gnomad NFE exome
AF:
0.0141
Gnomad OTH exome
AF:
0.0379
GnomAD4 exome
AF:
0.0300
AC:
43897
AN:
1461888
Hom.:
2430
Cov.:
33
AF XY:
0.0321
AC XY:
23323
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.276
AC:
9237
AN:
33480
American (AMR)
AF:
0.0289
AC:
1292
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0314
AC:
821
AN:
26136
East Asian (EAS)
AF:
0.0482
AC:
1912
AN:
39700
South Asian (SAS)
AF:
0.123
AC:
10588
AN:
86258
European-Finnish (FIN)
AF:
0.0133
AC:
711
AN:
53420
Middle Eastern (MID)
AF:
0.0697
AC:
402
AN:
5768
European-Non Finnish (NFE)
AF:
0.0145
AC:
16173
AN:
1112006
Other (OTH)
AF:
0.0457
AC:
2761
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2690
5380
8070
10760
13450
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0890
AC:
13537
AN:
152180
Hom.:
1447
Cov.:
32
AF XY:
0.0890
AC XY:
6625
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.253
AC:
10481
AN:
41470
American (AMR)
AF:
0.0524
AC:
801
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0366
AC:
127
AN:
3466
East Asian (EAS)
AF:
0.0460
AC:
238
AN:
5176
South Asian (SAS)
AF:
0.125
AC:
602
AN:
4824
European-Finnish (FIN)
AF:
0.0134
AC:
142
AN:
10612
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0136
AC:
925
AN:
68030
Other (OTH)
AF:
0.0834
AC:
176
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
545
1090
1635
2180
2725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0448
Hom.:
1180
Bravo
AF:
0.0993
Asia WGS
AF:
0.105
AC:
363
AN:
3478
EpiCase
AF:
0.0181
EpiControl
AF:
0.0191

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group P Benign:3
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 14, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 31, 2012
Leiden Open Variation Database
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:curation

Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.98
DANN
Benign
0.89
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28516461; hg19: chr16-3656557; COSMIC: COSV53564444; API